April 2021 virtual Open Pharma roundtable meeting report
Version 2 2021-06-08, 15:20
Version 1 2021-06-08, 14:26
online resource
posted on 2021-06-08, 15:20 authored by Francesca OunsworthFrancesca Ounsworth, Caitlin Edgell, Tim KoderTim Koder, Tanya Stezhka, Sarah Hewitt, Zoe WattsZoe Watts, Paul Farrow, Chris Winchester<p>On 23 April 2021, Members, Supporters
and Advisers of Open Pharma and a group of publishing company representatives met
for a virtual roundtable meeting to: </p>
<p>1.
identify the benefits and risks to pharma, publishers
and wider stakeholders in healthcare of open access (OA) agreements between
pharma and publishers</p>
<p>2. agree
whether there is a role for Open Pharma in future discussions on this topic.</p>
History
Related Materials
- 1.
